Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

242 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Determination and allelic allocation of seven nucleotide transitions within the arylamine N-acetyltransferase gene in the Polish population.
Mrozikiewicz PM, Cascorbi I, Brockmöller J, Roots I. Mrozikiewicz PM, et al. Among authors: cascorbi i. Clin Pharmacol Ther. 1996 Apr;59(4):376-82. doi: 10.1016/S0009-9236(96)90104-6. Clin Pharmacol Ther. 1996. PMID: 8612380
Arylamine N-acetyltransferase (NAT2) mutations and their allelic linkage in unrelated Caucasian individuals: correlation with phenotypic activity.
Cascorbi I, Drakoulis N, Brockmöller J, Maurer A, Sperling K, Roots I. Cascorbi I, et al. Am J Hum Genet. 1995 Sep;57(3):581-92. Am J Hum Genet. 1995. PMID: 7668286 Free PMC article.
Polymorphisms in the human CYP1A1 gene as susceptibility factors for lung cancer: exon-7 mutation (4889 A to G), and a T to C mutation in the 3'-flanking region.
Drakoulis N, Cascorbi I, Brockmöller J, Gross CR, Roots I. Drakoulis N, et al. Among authors: cascorbi i. Clin Investig. 1994 Feb;72(3):240-8. doi: 10.1007/BF00189321. Clin Investig. 1994. PMID: 7912124
Combined analysis of inherited polymorphisms in arylamine N-acetyltransferase 2, glutathione S-transferases M1 and T1, microsomal epoxide hydrolase, and cytochrome P450 enzymes as modulators of bladder cancer risk.
Brockmöller J, Cascorbi I, Kerb R, Roots I. Brockmöller J, et al. Among authors: cascorbi i. Cancer Res. 1996 Sep 1;56(17):3915-25. Cancer Res. 1996. PMID: 8752158
Homozygous rapid arylamine N-acetyltransferase (NAT2) genotype as a susceptibility factor for lung cancer.
Cascorbi I, Brockmöller J, Mrozikiewicz PM, Bauer S, Loddenkemper R, Roots I. Cascorbi I, et al. Cancer Res. 1996 Sep 1;56(17):3961-6. Cancer Res. 1996. PMID: 8752164
NAT2*12A (803A-->G) codes for rapid arylamine n-acetylation in humans.
Cascorbi I, Brockmöller J, Bauer S, Reum T, Roots I. Cascorbi I, et al. Pharmacogenetics. 1996 Jun;6(3):257-9. doi: 10.1097/00008571-199606000-00009. Pharmacogenetics. 1996. PMID: 8807666 No abstract available.
A C4887A polymorphism in exon 7 of human CYP1A1: population frequency, mutation linkages, and impact on lung cancer susceptibility.
Cascorbi I, Brockmöller J, Roots I. Cascorbi I, et al. Cancer Res. 1996 Nov 1;56(21):4965-9. Cancer Res. 1996. PMID: 8895751
Polymorphic enzymes of xenobiotic metabolism as modulators of acquired P53 mutations in bladder cancer.
Brockmöller J, Kaiser R, Kerb R, Cascorbi I, Jaeger V, Roots I. Brockmöller J, et al. Among authors: cascorbi i. Pharmacogenetics. 1996 Dec;6(6):535-45. doi: 10.1097/00008571-199612000-00007. Pharmacogenetics. 1996. PMID: 9014203
Peptide nucleic acid-mediated polymerase chain reaction clamping allows allelic allocation of CYP1A1 mutations.
Mrozikiewicz PM, Landt O, Cascorbi I, Roots I. Mrozikiewicz PM, et al. Among authors: cascorbi i. Anal Biochem. 1997 Aug 1;250(2):256-7. doi: 10.1006/abio.1997.2246. Anal Biochem. 1997. PMID: 9245448 No abstract available.
CYP1A1 mutations 4887A, 4889G, 5639C and 6235C in the Polish population and their allelic linkage, determined by peptide nucleic acid-mediated PCR clamping.
Mrozikiewicz PM, Cascorbi I, Brockmöller J, Roots I. Mrozikiewicz PM, et al. Among authors: cascorbi i. Pharmacogenetics. 1997 Aug;7(4):303-7. doi: 10.1097/00008571-199708000-00005. Pharmacogenetics. 1997. PMID: 9295058
242 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page
Feedback